Allogeneic Cell Therapy as Transplant Medicine: Replacing or Supporting Cells in Patients That Are Dysfunctional or Absent Due to Degenerative Disease or Traumatic Injury

Tuesday, April 25, 2023

10:00 AM – 10:30 AM ET

Location: Salon E, 5th Floor

Speaker(s)

Brian M. Culley, BS, MS, MBA

Chief Executive Officer
Lineage Cell Therapeutics, Inc.
Carlsbad, California, United States

Handouts

Allogeneic Cell Therapy as Transplant Medicine: Replacing or Supporting Cells in Patients That Are Dysfunctional or Absent Due to Degenerative Disease or Traumatic Injury

Learning Objectives:

Understand the evolution of cell therapy.
Understand how Lineage is working to become a leader in cell transplant medicine.
Understand and analyze cell therapy clinical data in dry-age related macular degeneration and spinal cord injury.